Brainsway BWAY
NASDAQ BWAY
$14.93 -0.24 (-1.62%)
At close: Aug 20, 2026 · 2:33 PM UTC

Brainsway (BWAY) Net Income towards Common Stockholders (2018 - 2026)

Brainsway's (BWAY) quarterly Net Income towards Common Stockholders came in at $2.3 million in Q1 2026, up 106.87% YoY from $1.1 million in Q1 2025, and down 31.13% on a QoQ basis from $3.3 million in Q4 2025.

Brainsway (BWAY) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

Brainsway (BWAY) has 9 years of Net Income towards Common Stockholders data on file, last reported at $2.3 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 106.87% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (up 135.08% YoY) and the FY2025 annual result came in at $7.6 million, up 159.33% from the prior year.
  • Net Income towards Common Stockholders declined to $2.3 million in Q1 2026, from $3.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $3.3 million in Q4 2025 to a low of -$5.0 million in Q3 2022.
  • A 5-year average of -$253529.4 and a median of $127000.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 187.08% — and 2024, when it soared 1118.9%.
  • Tracing BWAY's Net Income towards Common Stockholders over 5 years: stood at -$3.9 million in 2022, then surged by 103.28% to $127000.0 in 2023, then soared by 1118.9% to $1.5 million in 2024, then soared by 114.79% to $3.3 million in 2025, then sank by 31.13% to $2.3 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $2.3 million (Q1 2026), $3.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 621.86 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 201.00 Mn
10 Brainsway 567.23 Mn 504.06 Mn 12.77 Mn 2.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.29 Mn
Dec 31, 2025 3.33 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 1.11 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 662,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 127,000.00
Sep 30, 2023 -230,000.00
Jun 30, 2023 -1.66 Mn
Mar 31, 2023 -2.43 Mn
Dec 31, 2022 -3.87 Mn
Sep 30, 2022 -5.04 Mn
Jun 30, 2022 -2.45 Mn
Mar 31, 2022 -1.99 Mn
Dec 31, 2021 -1.35 Mn
Sep 30, 2021 -1.80 Mn
Jun 30, 2021 -1.94 Mn